Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery Mesothelin

Path Created with Sketch.
Go to Mesothelin Normal Tissue GalleryGo back to Product Page
Breast - Adenoid-cystic breast cancer with strong membranous mesothelin immunostaining in a subset of cells.
Breast – Adenoid-cystic breast cancer with strong membranous mesothelin immunostaining in a subset of cells.
Colon - Adenocarcinoma of the colon with weak to moderate, cytoplasmic and membranous mesothelin immunostaining.
Colon – Adenocarcinoma of the colon with weak to moderate, cytoplasmic and membranous mesothelin immunostaining.
Kidney - Clear cell renal cell carcinoma with moderate to strong cytoplasmic mesothelin immunostaining.
Kidney – Clear cell renal cell carcinoma with moderate to strong cytoplasmic mesothelin immunostaining.
Larynx - Squamous cell carcinoma of the larynx with moderate membranous mesothelin immunostaining in a small fraction of tumor cells.
Larynx – Squamous cell carcinoma of the larynx with moderate membranous mesothelin immunostaining in a small fraction of tumor cells.
Larynx - Squamous cell carcinoma of the larynx with strong membranous and cytoplasmic mesothelin immunostaining in the vast majority of cells.
Larynx – Squamous cell carcinoma of the larynx with strong membranous and cytoplasmic mesothelin immunostaining in the vast majority of cells.
Liver - Cholangiocellular carcinoma with cytoplasmic and membranous mesothelin positivity.
Liver – Cholangiocellular carcinoma with cytoplasmic and membranous mesothelin positivity.
Ovary - Intense, predominantly cytoplasmic mesothelin staining in a serous ovarian cancer.
Ovary – Intense, predominantly cytoplasmic mesothelin staining in a serous ovarian cancer.
Ovary - Mesothelin negative endometroid ovarian cancer.
Ovary – Mesothelin negative endometroid ovarian cancer.
Ovary - Strong, predominantly membranous mesothelin staining in an endometroid ovarian cancer.
Ovary – Strong, predominantly membranous mesothelin staining in an endometroid ovarian cancer.
Pancreas - Strong cytoplasmic and membranous mesothelin immunostaining of all cells of an adenocarcinoma of the pancreas.
Pancreas – Strong cytoplasmic and membranous mesothelin immunostaining of all cells of an adenocarcinoma of the pancreas.
Pancreas - Strong cytoplasmic and membranous mesothelin immunostaining with apical predominance in an adenocarcinoma of the pancreas.
Pancreas – Strong cytoplasmic and membranous mesothelin immunostaining with apical predominance in an adenocarcinoma of the pancreas.
Pancreas - Weak to moderate cytoplasmic and membranous mesothelin positivity with apical predominance in an adenocarcinoma of the pancreas.
Pancreas – Weak to moderate cytoplasmic and membranous mesothelin positivity with apical predominance in an adenocarcinoma of the pancreas.
Pleura - Malignant mesothelioma with strong membranous and cytoplasmic mesothelin immunostaining in epithelial and mesenchymal cells.
Pleura – Malignant mesothelioma with strong membranous and cytoplasmic mesothelin immunostaining in epithelial and mesenchymal cells.
Stomach - Strong, predominantly cytoplasmic mesothelin immunostaining in a stomach cancer with diffuse growth pattern.
Stomach – Strong, predominantly cytoplasmic mesothelin immunostaining in a stomach cancer with diffuse growth pattern.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors